Andy Beck is the co-founder and CEO of Path AI. Their platform vision is to bring substantial improvements to the accuracy of diagnosis and the prediction of therapeutic efficacy for diseases like cancer, leveraging modern approaches in machine learning.

Previously, Beck was an Associate Professor of Pathology at Harvard Medical School, where he published over 110 papers in cancer biology, pathology, and informatics.

Dr. Shivdev Rao is the co-founder and CEO of Abridge, a healthcare technology company that uses artificial intelligence to help patients and doctors capture and understand medical conversations. Founded in 2018, Abridge aims to improve the healthcare experience by transcribing and summarizing key points from medical visits, allowing patients to better understand and manage their care.

Rao, a former practicing cardiologist, was inspired to bridge the communication gap between patients and clinicians, leveraging technology to reduce confusion and improve health outcomes. Under his leadership, Abridge has become a pioneering force in the growing field of AI-driven healthcare solutions.

Latent Labs are a frontier AI lab building foundation models for protein design. Based in London and San Francisco the company is revolutionizing the development of biologics to accelerate the creation of next-generation therapies.

Prior to launching the company, Simon Kohl co-developed AlphaFold, built AlphaFold's widely used uncertainty prediction 'pLDDT', and co-led DeepMind's protein design team. 

‍

Dr. Alec Nielsen is an early pioneer in building design tools for synthetic biology.

‍

As the co-founder and CEO of Asimov, he is innovating a platform enabling mammalian cell synthetic biology—the software and cells making novel biologics and cell & gene therapies possible.